FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PHF21A-NUTF2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PHF21A-NUTF2
FusionPDB ID: 64851
FusionGDB2.0 ID: 64851
HgeneTgene
Gene symbol

PHF21A

NUTF2

Gene ID

51317

10204

Gene namePHD finger protein 21Anuclear transport factor 2
SynonymsBHC80|BM-006|IDDBCS|NEDMSNTF-2|NTF2|PP15
Cytomap

11p11.2

16q22.1

Type of geneprotein-codingprotein-coding
DescriptionPHD finger protein 21ABHC80aBRAF35-HDAC complex protein BHC80BRAF35/HDAC2 complex (80 kDa)nuclear transport factor 2placental protein 15
Modification date2020032720200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000257821, ENST00000323180, 
ENST00000418153, ENST00000527753, 
ENST00000219169, ENST00000568396, 
ENST00000569436, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score19 X 13 X 12=296412 X 9 X 6=648
# samples 2215
** MAII scorelog2(22/2964*10)=-3.75197001878117
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(15/648*10)=-2.11103131238874
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PHF21A [Title/Abstract] AND NUTF2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PHF21A [Title/Abstract] AND NUTF2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PHF21A(46098305)-NUTF2(67902243), # samples:3
Anticipated loss of major functional domain due to fusion event.PHF21A-NUTF2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PHF21A-NUTF2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneNUTF2

GO:0006606

protein import into nucleus

7744965|10679025

TgeneNUTF2

GO:0006611

protein export from nucleus

16449645



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:46098305/chr16:67902243)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PHF21A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NUTF2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000257821PHF21Achr1146098305-ENST00000219169NUTF2chr1667902243+271677716682117149
ENST00000257821PHF21Achr1146098305-ENST00000569436NUTF2chr1667902243+14727776241061145
ENST00000257821PHF21Achr1146098305-ENST00000568396NUTF2chr1667902243+14727776241061145
ENST00000323180PHF21Achr1146098305-ENST00000219169NUTF2chr1667902243+246052114121861149
ENST00000323180PHF21Achr1146098305-ENST00000569436NUTF2chr1667902243+1216521368805145
ENST00000323180PHF21Achr1146098305-ENST00000568396NUTF2chr1667902243+1216521368805145
ENST00000418153PHF21Achr1146098305-ENST00000219169NUTF2chr1667902243+229235312441693149
ENST00000418153PHF21Achr1146098305-ENST00000569436NUTF2chr1667902243+1048353200637145
ENST00000418153PHF21Achr1146098305-ENST00000568396NUTF2chr1667902243+1048353200637145

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000257821ENST00000219169PHF21Achr1146098305-NUTF2chr1667902243+0.0105377230.9894623
ENST00000257821ENST00000569436PHF21Achr1146098305-NUTF2chr1667902243+0.0067967720.99320316
ENST00000257821ENST00000568396PHF21Achr1146098305-NUTF2chr1667902243+0.0067967720.99320316
ENST00000323180ENST00000219169PHF21Achr1146098305-NUTF2chr1667902243+0.0068993970.99310064
ENST00000323180ENST00000569436PHF21Achr1146098305-NUTF2chr1667902243+0.0042781860.9957218
ENST00000323180ENST00000568396PHF21Achr1146098305-NUTF2chr1667902243+0.0042781860.9957218
ENST00000418153ENST00000219169PHF21Achr1146098305-NUTF2chr1667902243+0.0089843930.9910156
ENST00000418153ENST00000569436PHF21Achr1146098305-NUTF2chr1667902243+0.0041248340.9958752
ENST00000418153ENST00000568396PHF21Achr1146098305-NUTF2chr1667902243+0.0041248340.9958752

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PHF21A-NUTF2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PHF21Achr1146098305NUTF2chr166790224335350HELQAKITALSEKQIDASCLTWEGQQ
PHF21Achr1146098305NUTF2chr166790224352150HELQAKITALSEKQIDASCLTWEGQQ
PHF21Achr1146098305NUTF2chr166790224377750HELQAKITALSEKQIDASCLTWEGQQ

Top

Potential FusionNeoAntigen Information of PHF21A-NUTF2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PHF21A-NUTF2_46098305_67902243.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B48:01KQIDASCL0.99780.70861220
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B39:13KQIDASCL0.92980.94911220
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B45:01SEKQIDASC0.98010.79641019
PHF21A-NUTF2chr1146098305chr1667902243777HLA-A02:13ALSEKQIDA0.96970.5152817
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B50:02SEKQIDASC0.96040.51971019
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B41:01SEKQIDASC0.39160.80851019
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B50:01SEKQIDASC0.1270.64631019
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B57:01KQIDASCLTW0.9990.99561222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-A31:08KQIDASCLTW0.99550.95291222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B58:02KQIDASCLTW0.99480.98691222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B58:01KQIDASCLTW0.99330.9941222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B57:03KQIDASCLTW0.98980.99861222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B47:01KQIDASCLTW0.97070.81021222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-A32:13KQIDASCLTW0.96490.99011222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B13:01KQIDASCLTW0.83620.9981222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-A24:14KQIDASCLTW0.76850.80311222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B40:06SEKQIDASC0.98630.64121019
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B44:08KQIDASCLTW0.96460.95151222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:05KQIDASCLTW0.93190.93411222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B48:05KQIDASCL0.63560.61991220
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B50:05SEKQIDASC0.1270.64631019
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B50:04SEKQIDASC0.1270.64631019
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:24KQIDASCLTW0.99980.9941222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:53KQIDASCLTW0.99940.97331222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:135KQIDASCLTW0.99920.97451222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B57:10KQIDASCLTW0.9990.99561222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B57:04KQIDASCLTW0.99620.93311222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-A32:01KQIDASCLTW0.99330.99591222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B40:04SEKQIDASCL0.98820.68331020
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:54KQIDASCLTW0.9870.97021222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B58:06KQIDASCLTW0.98580.98751222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B57:02KQIDASCLTW0.9850.9961222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:13KQIDASCLTW0.95560.9851222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:68KQIDASCLTW0.94980.94351222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B48:02KQIDASCLTW0.93350.93811222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:20KQIDASCLTW0.9270.941222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B35:28KQIDASCLTW0.90820.941222
PHF21A-NUTF2chr1146098305chr1667902243777HLA-B15:24EKQIDASCLTW0.99260.97851122

Top

Potential FusionNeoAntigen Information of PHF21A-NUTF2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PHF21A-NUTF2_46098305_67902243.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-0123QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-0437HELQAKITALSEKQI015
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-0804HELQAKITALSEKQI015
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1201QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1201LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1201ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1201AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1203QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1203LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1203ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1203AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1204QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1204LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1205QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1205LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1205ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1205AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1206QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1206LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1206ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1206AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1207QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1207LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1207ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1207AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1208QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1208LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1208ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1208AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1209QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1209LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1210QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1210LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1210ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1210AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1211QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1211LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1211ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1211AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1212QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1212LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1212ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1212AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1213QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1213LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1213ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1213AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1214QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1214LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1214ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1214AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1215QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1215LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1215ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1215AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1216QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1216LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1216ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1216AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1217QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1217LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1217ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1217AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1218QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1218LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1218ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1218AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1219QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1219LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1219ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1219AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1220QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1220LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1220ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1220AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1221QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1221LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1221ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1221AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1222QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1222LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1223QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1223LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1223ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1223AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1354QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1377QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1377LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1415HELQAKITALSEKQI015
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1431QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1503QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1503LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1503ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1503AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1504QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1510QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1521QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1521LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1523QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1523LQAKITALSEKQIDA217
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1523ELQAKITALSEKQID116
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1523AKITALSEKQIDASC419
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1615QAKITALSEKQIDAS318
PHF21A-NUTF2chr1146098305chr1667902243777DRB1-1615LQAKITALSEKQIDA217

Top

Fusion breakpoint peptide structures of PHF21A-NUTF2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4010ITALSEKQIDASCLPHF21ANUTF2chr1146098305chr1667902243777

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PHF21A-NUTF2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4010ITALSEKQIDASCL-7.15543-7.26883
HLA-B14:023BVN4010ITALSEKQIDASCL-4.77435-5.80965
HLA-B52:013W394010ITALSEKQIDASCL-6.80875-6.92215
HLA-B52:013W394010ITALSEKQIDASCL-4.20386-5.23916
HLA-A11:014UQ24010ITALSEKQIDASCL-7.5194-8.5547
HLA-A11:014UQ24010ITALSEKQIDASCL-6.9601-7.0735
HLA-A24:025HGA4010ITALSEKQIDASCL-7.52403-7.63743
HLA-A24:025HGA4010ITALSEKQIDASCL-5.82433-6.85963
HLA-B27:056PYJ4010ITALSEKQIDASCL-3.28285-4.31815
HLA-B44:053DX84010ITALSEKQIDASCL-5.91172-6.94702
HLA-B44:053DX84010ITALSEKQIDASCL-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of PHF21A-NUTF2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
PHF21A-NUTF2chr1146098305chr16679022431019SEKQIDASCGAGAAACAGATTGACGCGTCATGCCTT
PHF21A-NUTF2chr1146098305chr16679022431020SEKQIDASCLGAGAAACAGATTGACGCGTCATGCCTTACG
PHF21A-NUTF2chr1146098305chr16679022431122EKQIDASCLTWAAACAGATTGACGCGTCATGCCTTACGTGGGAA
PHF21A-NUTF2chr1146098305chr16679022431220KQIDASCLCAGATTGACGCGTCATGCCTTACG
PHF21A-NUTF2chr1146098305chr16679022431222KQIDASCLTWCAGATTGACGCGTCATGCCTTACGTGGGAA
PHF21A-NUTF2chr1146098305chr1667902243817ALSEKQIDATTGAGTGAGAAACAGATTGACGCGTCA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
PHF21A-NUTF2chr1146098305chr1667902243015HELQAKITALSEKQIGAACTCCAAGCCAAAATCACAGCTTTGAGTGAGAAACAGATTGAC
PHF21A-NUTF2chr1146098305chr1667902243116ELQAKITALSEKQIDCTCCAAGCCAAAATCACAGCTTTGAGTGAGAAACAGATTGACGCG
PHF21A-NUTF2chr1146098305chr1667902243217LQAKITALSEKQIDACAAGCCAAAATCACAGCTTTGAGTGAGAAACAGATTGACGCGTCA
PHF21A-NUTF2chr1146098305chr1667902243318QAKITALSEKQIDASGCCAAAATCACAGCTTTGAGTGAGAAACAGATTGACGCGTCATGC
PHF21A-NUTF2chr1146098305chr1667902243419AKITALSEKQIDASCAAAATCACAGCTTTGAGTGAGAAACAGATTGACGCGTCATGCCTT

Top

Information of the samples that have these potential fusion neoantigens of PHF21A-NUTF2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BLCAPHF21A-NUTF2chr1146098305ENST00000257821chr1667902243ENST00000568396TCGA-2F-A9KP-01A

Top

Potential target of CAR-T therapy development for PHF21A-NUTF2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PHF21A-NUTF2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PHF21A-NUTF2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource